Edwards Lifesciences EW
NYSE EW
$85.80 +0.61 (+0.72%)
As of: Oct 2, 2026 · 11:45 AM EDT

Edwards Lifesciences (EW) Liabilities from Discontinued Operations (2023 - 2025)

Updated

Edwards Lifesciences' Liabilities from Discontinued Operations came in at $200,000 for Q3 2025.

Analysis

Edwards Lifesciences (EW) Liabilities from Discontinued Operations (2023 - 2025) Analysis & Trends

At the end of FY2023, Edwards Lifesciences' Liabilities from Discontinued Operations was $25.1 million.

  • The Q3 2025 figure represents the highest quarterly Liabilities from Discontinued Operations since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Agilent Technologies 48.58 Bn 41.47 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 200,000.00
Jun 30, 2024 30.00 Mn
Dec 31, 2023 25.10 Mn
API Access

Edwards Lifesciences Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=EW&period=max&api_key=YOUR_API_KEY